Zentalis Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Zentalis Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q2 2024.
  • Zentalis Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $33.5M, a 8.5% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $33.5M -$3.11M -8.5% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $34.7M -$2.75M -7.34% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $35.9M -$6.46M -15.2% Dec 31, 2023 10-Q 2024-08-09
Q3 2023 $36.2M -$6.46M -15.2% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $36.6M -$6.72M -15.5% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $37.5M -$6.17M -14.1% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $42.4M -$2.32M -5.19% Dec 31, 2022 10-K 2024-02-27
Q3 2022 $42.6M +$42M +6054% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $43.3M +$42.1M +3524% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $43.6M +$41.7M +2196% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $44.7M +$42.2M +1673% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $693K -$1.23M -64% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $1.2M -$895K -42.8% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $1.9M -$375K -16.5% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $2.52M +$185K +7.92% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $1.93M Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $2.09M Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $2.28M Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $2.34M Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.